Multiprofile Hospital for Active Treatment Targovishte AD

Targovishte 7700

0 studies enrolling now · 3 studies all time

What they study most

Bipolar I Disorder, COVID-19, Manic Episode

Studies at this site

• EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19 — Completed
• Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). — Stopped early
• A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder — Completed